How should glucocorticoid and mineralocorticoid replacement be optimised in a young patient with classic 21‐hydroxylase congenital adrenal hyperplasia?
Internal Medicine Journal · 2025
DOI: 10.1111/imj.70174 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Stephanie Teasdale und 3 weiteren Autor:innen. Beteiligte Einrichtung: Queensland Diabetes and Endocrine Centre, Mater Hospital Brisbane, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Glucocorticoids, Hormone Replacement Therapy, Mineralocorticoids. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
This article aims to provide a simple clinical approach to understanding and managing steroid supplementation in young adults and adult patients with classical congenital adrenal hyperplasia secondary to 21‐hydroxylase deficiency (21OHD). It aims to overcome the clinical inertia that leads to glucocorticoid excess in these patients, particularly addressing the adult endocrinologist at the transition when they meet the patient with 21OHD with ‘fresh eyes’.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Queensland Diabetes and Endocrine Centre, Mater Hospital Brisbane, Brisbane, Queensland, Australia.
- Faculty of Medicine, Mater Research Institute, University of Queensland, Brisbane, Queensland, Australia.
- Department of Endocrinology and Diabetes, Queensland Children's Hospital, Brisbane, Queensland, Australia.
- Children's Health Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
- Department of Chemical Pathology, Mater Pathology, Brisbane, Queensland, Australia.
- Children's Health Queensland, Clinical Unit, Greater Brisbane Clinical School, The Medical School, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
ORCID-Profile: Stephanie Teasdale, Louise S Conwell
Zitieren
APA
Teasdale, S., Joshi, K., Huynh, T., & Conwell, L. S. (2025). How should glucocorticoid and mineralocorticoid replacement be optimised in a young patient with classic 21‐hydroxylase congenital adrenal hyperplasia?. Internal Medicine Journal. https://doi.org/10.1111/imj.70174
Vancouver
Teasdale S, Joshi K, Huynh T, Conwell LS. How should glucocorticoid and mineralocorticoid replacement be optimised in a young patient with classic 21‐hydroxylase congenital adrenal hyperplasia?. Internal Medicine Journal. 2025. doi:10.1111/imj.70174
BibTeX
@article{Teasdale2025,
author = {Teasdale, Stephanie and Joshi, Kriti and Huynh, Tony and Conwell, Louise S},
title = {How should glucocorticoid and mineralocorticoid replacement be optimised in a young patient with classic 21‐hydroxylase congenital adrenal hyperplasia?},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.70174}
}
EUVIMED